Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$925,846,052
-$133,820,474 QoQ
Shares Held
1,708,739
-4.4% QoQ
Ownership
3.98%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#6
of 870 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (41.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $925,846,052 | 1,708,739 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,059,666,526 | 1,787,019 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $930,286,447 | 1,909,259 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $911,107,660 | 2,173,392 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $608,921,086 | 2,119,092 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $649,522,423 | 2,106,992 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $737,221,073 | 2,089,392 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $772,384,723 | 2,155,392 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $692,748,136 | 2,174,692 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $494,291,740 | 2,151,714 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $477,208,356 | 2,170,214 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $508,322,241 | 2,250,508 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $482,827,490 | 2,187,214 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $498,851,639 | 2,227,414 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $651,979,780 | 2,344,492 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $533,963,807 | 2,550,214 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $658,281,783 | 2,793,591 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $496,106,864 | 2,765,213 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $630,346,631 | 2,917,191 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $559,017,326 | 3,028,591 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $557,999,367 | 3,110,191 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $536,533,746 | 3,207,591 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $547,550,700 | 3,607,291 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $374,610,818 | 3,709,018 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $450,944,978 | 3,726,818 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $340,460,847 | 3,590,223 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||